*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T465X5A - Adverse effect of other antihypertensive drugs, initial encounter - as a primary diagnosis code | T465X5A - Adverse effect of other antihypertensive drugs, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.7 | |
| Readmission Rate (%) | 21.08 | |
| Unplanned Readmission Rate (%) | 18.48 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 59 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter in DRG | 62.77 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 2.44 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $246,503 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $1,712 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $4,178 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $1,467,471 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $24,872 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 74.58 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 312: SYNCOPE AND COLLAPSE | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 243,742 | ||||
| Total Hospitalizations with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 5,346 | ||||
| DRG Share of Total Hospitalizations | 0.74 | ||||
| % of Total ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter in DRG | 16.27 | ||||
| Avg LOS at DRG | 2.84 | ||||
| Avg LOS with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 2.73 | ||||
| Readmission Rate at DRG | 16.31 | ||||
| Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 18.55 | ||||
| Unplanned Readmission Rate at DRG | 11.3 | ||||
| Unplanned Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 13.02 | ||||
| Total Medicare payments at DRG | $1,150,233,161 | ||||
| Total Medicare payments with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $25,620,231 | ||||
| Total Medicare payment per Day at DRG | $1,663 | ||||
| Total Medicare payment per Day with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $1,755 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,719 | ||||
| Total Medicare payment per Hospitalization with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $4,792 | ||||
| Total Medicare Charges at DRG | $6,931,408,244 | ||||
| Total Medicare Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $138,899,311 | ||||
| Avg Charges at DRG | $28,437 | ||||
| Avg Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $25,982 | ||||
| Mortality Rate at DRG | 0.31 | ||||
| Mortality Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 18.06 | ||||
| SNF Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 16.11 | ||||
| Home Discharge Rate at DRG | 53.49 | ||||
| Home Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 55.41 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 292,335 | ||||
| Total Hospitalizations with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 982 | ||||
| DRG Share of Total Hospitalizations | 0.89 | ||||
| % of Total ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter in DRG | 2.99 | ||||
| Avg LOS at DRG | 2.96 | ||||
| Avg LOS with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 3.08 | ||||
| Readmission Rate at DRG | 19.18 | ||||
| Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 16.15 | ||||
| Unplanned Readmission Rate at DRG | 13.96 | ||||
| Unplanned Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 12.33 | ||||
| Total Medicare payments at DRG | $1,347,436,356 | ||||
| Total Medicare payments with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $4,567,050 | ||||
| Total Medicare payment per Day at DRG | $1,557 | ||||
| Total Medicare payment per Day with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $1,509 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,609 | ||||
| Total Medicare payment per Hospitalization with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $4,651 | ||||
| Total Medicare Charges at DRG | $7,385,462,160 | ||||
| Total Medicare Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $25,945,154 | ||||
| Avg Charges at DRG | $25,264 | ||||
| Avg Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $26,421 | ||||
| Mortality Rate at DRG | 0.57 | ||||
| Mortality Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 11.55 | ||||
| SNF Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 13.75 | ||||
| Home Discharge Rate at DRG | 63.79 | ||||
| Home Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 57.54 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 684: RENAL FAILURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 916: ALLERGIC REACTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 221,460 | ||||
| Total Hospitalizations with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 459 | ||||
| DRG Share of Total Hospitalizations | 0.67 | ||||
| % of Total ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter in DRG | 1.4 | ||||
| Avg LOS at DRG | 2.1 | ||||
| Avg LOS with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 2.36 | ||||
| Readmission Rate at DRG | 11.15 | ||||
| Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 11.39 | ||||
| Unplanned Readmission Rate at DRG | 7.88 | ||||
| Unplanned Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 9.34 | ||||
| Total Medicare payments at DRG | $635,922,710 | ||||
| Total Medicare payments with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $1,365,501 | ||||
| Total Medicare payment per Day at DRG | $1,367 | ||||
| Total Medicare payment per Day with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $1,263 | ||||
| Total Medicare payment per Hospitalization at DRG | $2,872 | ||||
| Total Medicare payment per Hospitalization with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $2,975 | ||||
| Total Medicare Charges at DRG | $4,179,979,444 | ||||
| Total Medicare Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $8,999,146 | ||||
| Avg Charges at DRG | $18,875 | ||||
| Avg Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $19,606 | ||||
| Mortality Rate at DRG | 0.21 | ||||
| Mortality Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 4.01 | ||||
| SNF Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 9.37 | ||||
| Home Discharge Rate at DRG | 82.23 | ||||
| Home Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 67.97 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,522,684 | ||||
| Total Hospitalizations with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 374 | ||||
| DRG Share of Total Hospitalizations | 4.63 | ||||
| % of Total ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter in DRG | 1.14 | ||||
| Avg LOS at DRG | 2.52 | ||||
| Avg LOS with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 3.52 | ||||
| Readmission Rate at DRG | 9.03 | ||||
| Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 11.48 | ||||
| Unplanned Readmission Rate at DRG | 3.35 | ||||
| Unplanned Readmission Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 3.08 | ||||
| Total Medicare payments at DRG | $17,672,828,347 | ||||
| Total Medicare payments with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $4,771,984 | ||||
| Total Medicare payment per Day at DRG | $4,606 | ||||
| Total Medicare payment per Day with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $3,623 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
| Total Medicare payment per Hospitalization with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $12,759 | ||||
| Total Medicare Charges at DRG | $91,836,200,128 | ||||
| Total Medicare Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $24,726,442 | ||||
| Avg Charges at DRG | $60,312 | ||||
| Avg Charges with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | $66,113 | ||||
| Mortality Rate at DRG | 0.05 | ||||
| Mortality Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 23.53 | ||||
| SNF Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 31.02 | ||||
| Home Discharge Rate at DRG | 30.67 | ||||
| Home Discharge Rate with ICD T465X5A - Adverse effect of other antihypertensive drugs, initial encounter | 18.72 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 127 |
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 122 |
| BEAUMONT HOSPITAL ROYAL OAK | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073 | 102 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. EDITH NEBUWA ANIEDOBE | 1500 FOREST GLEN RD | SILVER SPRING | MD | 20910 | 12 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 29 |
| Dr. MORAD L EL-RAHEB | 1145 S UTICA AVE | TULSA | OK | 74104 | 17 |
| Dr. MISAM ZAWIT | 2525 S MICHIGAN AVE | CHICAGO | IL | 60616 | 16 |